Calendar

21 CFR 820.30 21 CFR Part 820 510(k) 510(k) Contents and Format 510(k) format and content 510(k) Requirements 510(k)s 510k 510k In Person Seminar 510k LIVE seminar 510k LIVE Webinar 510K Seminar 510k submission Adverse Event Reporting Adverse Event Reporting Systems Advertising and Promotion AERS AIMDD ANDA Animal Drugs Asian Country Big Data Biocompatibility Biologics Biosimilars BLA CAPA CDRH CE Mark China Complaint Complaint Handling David Lim Design Control Dr. David Lim Drugs EMA EN ISO 13485:2012 EN ISO 14971:2012 EU EU Marketing Authorization Application (MAA) FDA FDA 510(k) FDA 510(k) Seminar: Best Practices for 510(k) Preparation FDA Guidance FDA Inspection FDA-Regulated Industry FMEA Fundamentals of Regulatory Affairs Generics Global Compliance Seminar Hatch-Waxman Act Healthcare Industry Hong Kong Human Drug IDE IND ISO 13485 ISO 14155 IVDD IVDs Japan Korea Laws and Regulations LIVE 510(k) Webinar LIVE Online Seminar LIVE Webinar MAA to EMA in EU Mandatory Adverse Event Reporting Marketing Approvals for Generic Medicines MDD MDR Medical Device Medical Device Reporting Medical Devices Medicine NDA Opioid Abuse Opioid Addiction Opioids Pain Management Paragraph IV Certification Patent Patent Exclusivity PMA PMA Drafting Seminar PMA Seminar PMAs Postmarket Surveillance Postmarket Vigilance Pre-submission Premarket Approval Premarket Notification Q-Submission QSR Quality Risk Management Quality System Regulation Recorded Recorded 510k Seminar Recorded PMA Seminar reference listed drug Regulatory Affairs Regulatory Doctor Regulatory Plan Regulatory Plan/Strategy Regulatory Requirements Regulatory Strategy Risk Analysis Risk Management RLD Safety Signals Social Media Marketing Social Media Practice Social Media Practices SOPs Submission and Clearance | Global Compliance Seminar substantial equivalence UDI Unique Device Identification Unique Device Identifier US FDA US FDA 510(k) US RAC Exam Writing an Effective SOP